Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows

v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net loss $ (60,839) $ (45,333)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment of other long-lived assets 919 3,865
Depreciation and amortization 24,343 29,924
Stock-based compensation 16,263 17,364
Foreign currency transaction loss 1,967 10,318
Share in losses of associated companies 7,343 174
Revaluation of investments 1,217 2,316
Other non-cash items, net 2,073 168
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (11,156) (11,058)
Inventories (11,161) (39,162)
Other current assets and prepaid expenses (3,777) 5,320
Other non-current assets 4,642 382
Accounts payable (4,360) 10,217
Other current liabilities (8,972) (20,650)
Deferred revenues 3,715 4,540
Deferred income taxes, net and uncertain tax positions 2,810 (1,674)
Other non-current liabilities (6,194) (5,620)
Net cash used in operating activities (41,167) (38,909)
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (66,472)
Purchase of property and equipment (6,546) (7,526)
Investments in short-term bank deposits (12,448) (195,429)
Proceeds from short-term bank deposits 128,815 272,000
Purchase of intangible assets (464) (965)
Other investing activities (58) 122
Investments in unconsolidated entities (6,199) (5,030)
Net cash provided by investing activities 36,628 63,172
Cash flows from financing activities    
Proceeds from exercise of stock options 9 247
Payment of contingent consideration (691) (1,386)
Other financing activities   275
Net cash used in financing activities (682) (864)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (824) (7,413)
Net change in cash, cash equivalents and restricted cash (6,045) 15,986
Cash, cash equivalents and restricted cash, beginning of period 150,686 243,293
Cash, cash equivalents and restricted cash, end of period 144,641 259,279
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 5,612 1,150
Transfer of fixed assets to inventory 118 123
Issuance of Common stock under employee stock purchase plan 3,014  
Issuance of shares as part of Covestro acquisition (Refer to Note 3) 5,201  
Contingent consideration 3,009  
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 144,366 255,886
Restricted cash included in other current assets 275 160
Cash balances classified as Held for sale 3,233
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 144,641 $ 259,279